INTELLIA THERAPEUTICS, INC. Other Non-Current Liabilities
INTELLIA THERAPEUTICS, INC. (NTLA) had Other Non-Current Liabilities of $10.79 million as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2022-08-04
- 2022-06-30: Other Liabilities, Noncurrent $10.79M.
- 2022-03-31: Other Liabilities, Noncurrent $10.96M.
- 2021-12-31: Other Liabilities, Noncurrent $0.00.
- 2018-12-31: Other Liabilities, Noncurrent $13.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2022-06-30 | $10.79M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $10.96M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $0.00 10-Q · filed 2022-08-04 |
| 2018-12-31 | $13.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $52.00K 10-Q · filed 2018-10-31 |
| 2018-06-30 | $92.00K 10-Q · filed 2018-08-01 |
| 2018-03-31 | $131.00K 10-Q · filed 2018-05-01 |
| 2017-12-31 | $168.00K 10-K · filed 2019-02-27 |
| 2017-09-30 | $201.00K 10-Q · filed 2017-10-31 |
| 2017-06-30 | $234.00K 10-Q · filed 2017-08-01 |
| 2017-03-31 | $378.00K 10-Q · filed 2017-05-02 |
| 2016-12-31 | $293.00K 10-K · filed 2018-03-14 |
| 2016-09-30 | $306.00K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $363.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $349.00K 10-Q · filed 2016-06-03 |
| 2015-12-31 | $323.00K 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |